IE 11 is not supported. For an optimal experience visit our site on another browser.

Moderna begins Phase 3 human trials for coronavirus vaccine, recruiting 30,000 volunteers


Half of the volunteers will receive the vaccine and half will receive a placebo. Moderna has received nearly $1 billion in federal funding and promises to produce 500 million doses per year. Other companies are expected to progress to late stage trials soon.